After completing the course, the reader will be able to:1. Educate community oncologists about the promise of anti-CTLA-4 monoclonal antibodies for the treatment of advanced cancer. 2. Suggest that CTLA-4 blockade overcomes barriers to effective immunotherapy for cancer. 3. Describe the rational design and clinical development strategy taken with the CTLA-4 antagonist tremelimumab.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit ™ at CME.TheOncologist.com CME CME
ABSTRACT
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.